Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common forms of non-melanoma skin cancers. They have a wide clinical and pathological presentation, and early detection and treatment is vital to reduce the morbidity and mortality associated with these diseases.
In this podcast, our multidisciplinary panel discuss:
- the pathology and aetiology of SCCs and BCCs
- when a GP should refer their patient
- the role of surgery
- when radiotherapy is indicated in the definitive and adjuvant setting
- how systemic therapy can play a role in advanced disease.
In addition, the panel review two cases to solidify the learnings.
This podcast is suitable for Medical Oncologists, Surgeons, Dermatologists, GPs, Nurses and other healthcare professionals.
Please note that this podcast was accurate at the time of recording (March 2021) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
Dr Robert Rawson - Pathologist, Melanoma Institute Australia and Royal Prince Alfred Hospital
Dr Kerwin Shannon - Surgical Oncologist and Head and Neck Surgeon, Melanoma Institute Australia and Chris O’Brien Lifehouse
Prof Angela Hong - Radiation Oncologist, Melanoma Institute Australia |Clinical Professor, The University of Sydney
Dr Ines Silva - Medical Oncologist and Researcher, Melanoma Institute Australia | Fellow, Westmead Hospital